Patrick Brennecke

Patrick Brennecke serves as the Associate Director of Bioanalytical Strategy and Vendor Governance Lead at UCB since November 2022, overseeing global bioanalytical strategies. Prior to this role, Patrick held the position of Group Head for DPS Bioanalytics at Lonza, where leadership was provided in a cGMP environment. At Celerion, Patrick served as Technical Director of Bioanalytical Translational Science, managing biomarker and PK method development, as well as interfacing with business development initiatives. Earlier experience includes a directorial role at Alpinia Laudanum, focusing on immunology and cancer research, while also holding board responsibilities. Patrick’s educational background features a CAS in Corporate Finance from the University of Zurich, postdoctoral studies in Immuno-Oncology from HUMANITAS RESEARCH HOSPITAL, and a PhD in Tumor Biology from ETH Zürich.